Clinical diagnostic and treatment of COVID 19 of bilateral pneumonia: Case report
Abstract
In 2019 year the world was attacked with corona virus (SARS-CoV-2) and in march 2020, the World Health Organization (WHO) declared the COVID-19 outbreak a pandemic.The symptoms and clinical state in this COVID-19 infection was different, from asymptomatic to mild and severe symptoms, which presented different form of disease: mild, moderate or severe, with or without complications. We presented case with COVID 19 pneumonia as one of the form of COVID infection, with diagnosis, treatment and all investigations we done in our hospital. With complex treatment of this virus infection we successful improved the clinical state of patients with COVID 19 pneumonia.
Keywords: coronavirus, SARS-CoV-2, COVID-19, COVID 19 pneumonia
Keywords:
coronavirus, SARS-CoV-2, COVID-19, COVID 19 pneumoniaDOI
https://doi.org/10.22270/jddt.v11i2-S.4623References
Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern.Lancet. 2020 Feb 15; 395(10223):470-473.
Cate Wood. Infections without borders: a new coronavirus in Wuhan, China.Br J Nurs.. 2020 Feb 13; 29(3):166-167.
Dhama K, Khan S, Tiwari R, Sircar S, Bhat S, Malik YS, Singh KP, Chaicumpa W, D Bonilla-Aldana K, Rodriguez-Morales AJ. Coronavirus Disease 2019-COVID-19.ClinMicrobiol Rev. 2020 Jun 24; 33(4):e00028-20
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.Lancet. 2020 Feb 15; 395(10223):497-506.
Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Raffaela Di Napol Features, Evaluation, and Treatment of Coronavirus.StatPearls, October 4, 2020.
Seibert FS, Toma D, Bauer F, Paniskaki K, Detection of SARS-CoV-2 pneumonia: two case reports. Journal of Medical Case Reports. 2020, volume 14, Article number: 242.
Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DKW, Bleicker T, Brunink S, Schneider J, Schmidt ML, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020; 25:2.
Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020 Apr 13
Zarogoulidis P, Papanas N, Kioumis I, Chatzaki E, Maltezos E, Zarogoulidis K. Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases. Eur J Clin Pharmacol. 2012 May; 68(5):479-503
Kollias A, Kyriakoulis KG, Dimakakos E, Poulakou G, Stergiou GS, Syrigos K. Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action. Br J Haematol. 2020 Jun; 189(5):846-847
Published
Abstract Display: 518
PDF Downloads: 780
PDF Downloads: 748 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

.